Generics Market Overview in Canada

• Publication date: September 2009

It includes updated figures on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. Scope * Contains an executive summary and data on value, volume and/or key market segments * Provides textual analysis of the market ’s recent performance and future prospects * Incorporates in-d...

It includes updated figures on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information.

Scope


* Contains an executive summary and data on value, volume and/or key market segments


* Provides textual analysis of the market ’s recent performance and future prospects


* Incorporates in-depth environment and competition analysis and scorecards (substitution threats, new entrants, bargaining power …)


* Includes a 5 year Market forecast


* The main industry players are profiled with supporting key financial metrics


* Supported by the key macroeconomic and demographic data affecting the industry

Key Market Facts


* Detailed information is included on industry size, measured by value and/or volume


* Five forces scorecards provide an accessible yet in depth view of the industry ’s key competitors

This Report Will Support Your Decision Making Process


* Anticipate Industry trends and developments


* Feed your decision making process


* Make your presentation and marketing materials more valuable


* Save time

Market Definition

The generic drugs industry consists of all sales of generic drugs for human use at ex-manufacturer prices. Datamonitor defines a generic as an officially-approved copy of an original product whose patent has expired, industry ed either as a brand or using the generic name.

This definition excludes multi-source copy products that make up much of industry s such as India, Spain and Italy. Multi-source copies are drugs still under patent that are offered by manufacturers other than the patent holders. All currency conversions have been calculated at constant 2008 average exchange rates.

For the purpose of this market research report the Americas is deemed to comprise of Argentina, Brazil, Canada, Chile, Colombia, Mexico, Venezuela, and the US.

Generic Drug Industry in Canada

TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Industry Overview 7
1.1 Industry Definition 7
1.2 Research Highlights 7
1.3 Industry Analysis 8
CHAPTER 2 Industry Value 9
CHAPTER 3 Industry Segmentation I 10
CHAPTER 4 Industry Segmentation II 11
CHAPTER 5 Five Forces Analysis 12
5.1 Summary 12
5.2 Buyer Power 14
5.3 Supplier Power 15
5.4 New Entrants 16
5.5 Substitutes 17
5.6 Rivalry 18
CHAPTER 6 Leading Firms 19
6.1 Apotex, Inc. 19
6.2 Teva Pharmaceutical Market 21
6.3 King Pharmaceuticals, Inc 25
CHAPTER 7 Industry Projections 28
7.1 Industry Value Projection 28
CHAPTER 8 Macroeconomic Indicators 29
CHAPTER 9 Appendix 31
9.1 Methodology 31
9.2 Market Associations 32
9.3 Related Datamonitor Research 32

Index of Tables
Data table 1: Canada Generic Drugs Industry Value: USD billion, from 2004 to 2008 9
Data table 2: Canada Generic Drugs Industry Segmentation I: % Share, by Value, 2008 10
Data table 3: Canada Generic Drugs Industry Segmentation II: % Share, by Value, 2008 11
Data table 4: Key Facts: Apotex, Inc. 19
Data table 5: Key Facts: Teva Pharmaceutical Market 21
Data table 6: Key Financials: Teva Pharmaceutical Market 24
Data table 7: Key Facts: King Pharmaceuticals, Inc 25
Data table 8: Key Financials: King Pharmaceuticals, Inc 27
Data table 9: Canada Generic Drugs Industry Value Projection : USD billion, from 2008 to 2013 28
Data table 10: Canada Size of Population (million), from 2004 to 2008 29
Data table 11: Canada Gross Domestic Product (Constant 2000 Prices, USD billion), from 2004 to 2008 29
Data table 12: Canada Inflation, from 2004 to 2008 29
Data table 13: Canada Exchange Rate, from 2004 to 2008 30

Generic Drug in Canada

Canada Generic Drug Sales, Us$bn, % Chg Y-o-y

• $ 250
• Industry data
• January 2013

Yearly, From 2006 To 2021
By Business Monitor International
Source: Canadian Generic Pharmaceutical Association (CGPA), Patented Medicine Prices Review Board (PMPRB), B

• Industries : Generic Drug
• Countries : Canada

Canada Generic Drug Sales, Us$bn

• $ 250
• Industry data
• January 2013

Yearly, From 2005 To 2021
By Business Monitor International
Source: Canadian Generic Pharmaceutical Association (CGPA), Patented Medicine Prices Review Board (PMPRB), B

• Industries : Generic Drug
• Countries : Canada

Canada Generic Drug Sales, Us$bn, 5 Year Trailing Cagr, %

• $ 250
• Industry data
• January 2013

Yearly, From January 01, 2012 To January 01, 2012
By Business Monitor International
Source: Canadian Generic Pharmaceutical Association (CGPA), Patented Medicine Prices Review Board (PMPRB), B

• Industries : Generic Drug
• Countries : Canada

Canada Generic Drug Sales, Us$bn, 5 Year Forward Cagr, %

• $ 250
• Industry data
• January 2013

Yearly, From January 01, 2012 To January 01, 2012
By Business Monitor International
Source: Canadian Generic Pharmaceutical Association (CGPA), Patented Medicine Prices Review Board (PMPRB), B

• Industries : Generic Drug
• Countries : Canada

Canada Generic Drug Sales, Us$bn, 10 Year Forward Cagr, %

• $ 250
• Industry data
• January 2013

Yearly, From January 01, 2012 To January 01, 2012
By Business Monitor International
Source: Canadian Generic Pharmaceutical Association (CGPA), Patented Medicine Prices Review Board (PMPRB), B

• Industries : Generic Drug
• Countries : Canada